← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Hager Biosciences, Llc
Bethlehem, PA
$6,997,939
Total funding
5
Grants
Funding over time
peak $5.6M · FY2011–24$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,997,939 · 5
By mechanism
UF1$5,598,515 · 1
R43$1,099,451 · 3
R41$299,973 · 1
Investigators at Hager Biosciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Development of Novel Dual OXR/KOR Antagonists for Treatment of Substance Use Disorder$5,598,515
UF1 · FY2021 · DA
Optimization of Novel Potassium Channel Kv1.3 Blockers with Potential as Alzheimer's Disease Therapeutics$499,968
R43 · FY2024 · AG
Multi-targeted Countermeasures against Acute and Delayed Effects of OP Exposure$374,488
R43 · FY2013 · ES
Developing Novel Dual CRF-R1/Orexin-1 Receptor Antagonists for Tobacco Dependence$299,973
R41 · FY2011 · DA
Multi-targeted Ligands to Treat Chronic Neuropathic Pain$224,995
R43 · FY2015 · NS